NTRR Initiates Research Into New Cannabis Topical Products

TAMPA, Fla.--()--As the best year yet for the U.S. cannabis industry draws to a close, Neutra Corp. (OTCQB: NTRR) is already prepping to continue its climb in 2016. The company announced today that it began preliminary research into new, cutting-edge topical creams, oils, salves and lotions infused with cannabis.

“Our market research, which has involved speaking with retailers and business owners across all of North America’s top cannabis markets, indicates that there is strong demand for these kinds of products that is still growing,” said NTRR CEO Chris Brown. “Cannabis is useful in treating so many kinds of issues—particularly pain—that it’s only natural that consumers be intrigued by adding cannabinoids to the same sorts of body-care products they already use and enjoy. We believe the market potential for infused topicals is massive.”

Using topicals, patients can apply cannabis’ medicinal properties to minor maladies such as bug bites, cuts, bruises, sore muscles, sunburn, arthritis and many more. As such, these products have enjoyed a recent surge in popularity as they are discovered by more and more consumers. Washington-based Kush Creams won the Best Product award at the Seattle Cannabis Cup in 2013, and other companies such as Colorado’s Mary’s Medicinals have rocketed to success and prominence by offering innovative topical solutions.

NTRR has already begun the earliest stages of due diligence on new topicals, with the goal of eventually licensing its topical recipes to partners beginning in the 23 states where medical cannabis is currently legal and regulated.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contacts

Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com

Release Summary

NTRR explores cannabis topicals

Contacts

Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com